Ajax-Loading

Novartis AG - Ebitda Interest Coverage

Novartis AG's Fiscal Year is From January To December.

The item "Ebitda-Interest-Coverage" stands at 20.39 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Ebitda Interest Coverage" stands at 20.39. This represents an increase of 0.21 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.12 percent compared to the value the year prior.
The 1 year change in percent is 1.12.
The 3 year change in percent is -45.94.

The Serie's long term average value is 23.97. It's latest available value, on 09/30/2025, is 14.93 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +9.59%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -50.21%.

Ebitda Interest Coverage for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Interest Coverage905,699,262,464.00
LogoJohnson & Johnson - Ebitda Interest Coverage486,508,953,600.00
LogoAbbVie Inc - Ebitda Interest Coverage399,570,305,024.00
LogoRoche Holding AG - Ebitda Interest Coverage317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Interest Coverage280,205,508,085.11